Year
|
First Author
|
Design
|
NAFLD (N)/ Total (N)
|
Country
|
Age (Years)
|
Gender (% Male)
|
Method of diagnosis of sarcopenia
|
Method of diagnosis of NAFLD
|
Method of diagnosis of liver fibrosis
|
Study quality1
|
---|
2017
|
Petta [12]
|
Cross-sectional
|
225/225
|
Italy
|
48.3
|
62.7
|
BIA
|
Liver biopsy
|
Liver biopsy
|
8
|
2017
|
Koo [13]
|
Cross-sectional
|
240/309
|
Korea
|
53
|
46.9
|
BIA
|
Liver biopsy
|
Liver biopsy
|
9
|
2016
|
Lee [15]a
|
Cross-sectional
|
2761/2761
|
Korea
|
55.8
|
55
|
DXA
|
NLFS [32]
|
NFS [33]
|
6
|
- BIA, Bioelectric impedance analysis, DXA Dual energy X-ray absorptiometry, LSM liver stiffness measurement, NLFS NAFLD liver fat score, NFS The NAFLD fibrosis score
- aNAFLD and liver fibrosis was defined using different prediction models, data of the first method was caculated and presented
- 1Methodological quality of included studies assessed using a method based in the 9-star Newcastle-Ottawa Scale